3//SEC Filing
Nestle Health Science US Holdings, Inc. 3
Accession 0000899243-20-011293
CIK 0001631650other
Filed
Apr 23, 8:00 PM ET
Accepted
Apr 24, 4:47 PM ET
Size
11.6 KB
Accession
0000899243-20-011293
Insider Transaction Report
Form 3
Societe des Produits Nestle S.A.
10% Owner
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
NESTLE SA
10% Owner
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
NIMCO US, Inc.
10% Owner
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
Nestle US Holdco, Inc.
10% Owner
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
Holdings
- 11,727,113(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]This Form 3 is being filed to reflect the additions of Nestle US Holdco, Inc. ("Nestle US Holdco") and Societe des Produits Nestle S.A. ("SPN") as Reporting Owners as a result of a corporate reorganization completed December 31, 2018.
- [F2]Held by Nestle Health Science US Holdings, Inc. ("NHS"). Following the corporate reorganization, NHS is a wholly owned subsidiary of NIMCO US, Inc. ("NIMCO"). NIMCO, in turn, is a wholly-owned subsidiary of Nestle US Holdco, which is a wholly-owned subsidiary of SPN. The ultimate parent company of NHS, NIMCO, Nestle US Holdco and SPN is Nestle S.A. ("Nestle"). Following the corporate reorganization, each of these entities may be deemed to share voting and investment power with respect to all shares of Common Stock held by NHS. Each of NIMCO, Nestle US Holdco, SPN and Nestle disclaims beneficial ownership of such shares of Common Stock except to the extent of its pecuniary interest therein.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001644164
Filing Metadata
- Form type
- 3
- Filed
- Apr 23, 8:00 PM ET
- Accepted
- Apr 24, 4:47 PM ET
- Size
- 11.6 KB